OR WAIT null SECS
May 02, 2009
Brief pharmaceutical news items for May 2009.
Technology can solve enterprise-level problems.
May 01, 2009
Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.
Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.
April 30, 2009
Also, Roche's Avastin trial does not meet endpoint; Innate Pharma names regulatory VP; more...
April 23, 2009
Also: Sanofi-aventis acquires BiPar Sciences; FDA issues Warning Letter to Chinese heparin manufacturer; Halo Pharmaceutical appoints chief scientific officer; more...
April 16, 2009
Also, Sanofi-aventis acquires Medley and Laboratorios Kendrick; Eli Lilly's Cook to retire from board; more...
April 09, 2009
Also, Genzyme and Bayer HealthCare form agreement; FDA releases draft guidances; TransMolecular appointed Robert Radie president and CEO
April 02, 2009
Also, SOCMA changes name; two FDA approvals; Biogen Idec names chief operating officer; more...
Obama's cost-containment and science-innovation initiatives need to overlap.